Chlorine in PDB 6bh0: Linked KDM5A Jmj Domain Bound to the Inhibitor (R)-2-((2- Chlorophenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)-1L2-Pyrrolo[3,2- B]Pyridine-7-Carboxylic Acid (Compound N51)

The structure of Linked KDM5A Jmj Domain Bound to the Inhibitor (R)-2-((2- Chlorophenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)-1L2-Pyrrolo[3,2- B]Pyridine-7-Carboxylic Acid (Compound N51), PDB code: 6bh0 was solved by J.R.Horton, X.Cheng, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	32.95 / 1.99
Space group	C 1 2 1
Cell size a, b, c (Å), α, β, γ (°)	116.813, 61.954, 46.858, 90.00, 92.36, 90.00
R / Rfree (%)	18.8 / 21.9

The structure of Linked KDM5A Jmj Domain Bound to the Inhibitor (R)-2-((2- Chlorophenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)-1L2-Pyrrolo[3,2- B]Pyridine-7-Carboxylic Acid (Compound N51) also contains other interesting chemical elements:

Manganese

(Mn)

1 atom

The binding sites of Chlorine atom in the Linked KDM5A Jmj Domain Bound to the Inhibitor (R)-2-((2- Chlorophenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)-1L2-Pyrrolo[3,2- B]Pyridine-7-Carboxylic Acid (Compound N51) (pdb code 6bh0). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Linked KDM5A Jmj Domain Bound to the Inhibitor (R)-2-((2- Chlorophenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)-1L2-Pyrrolo[3,2- B]Pyridine-7-Carboxylic Acid (Compound N51), PDB code: 6bh0:

Chlorine binding site 1 out of 1 in the Linked KDM5A Jmj Domain Bound to the Inhibitor (R)-2-((2- Chlorophenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)-1L2-Pyrrolo[3,2- B]Pyridine-7-Carboxylic Acid (Compound N51)


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Linked KDM5A Jmj Domain Bound to the Inhibitor (R)-2-((2- Chlorophenyl)(2-(Piperidin-1-Yl)Ethoxy)Methyl)-1L2-Pyrrolo[3,2- B]Pyridine-7-Carboxylic Acid (Compound N51) within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl601 b:32.2 occ:1.00 CL1 A:DO1601 0.0 32.2 1.0 C13 A:DO1601 1.7 27.3 1.0 C12 A:DO1601 2.7 26.2 1.0 C08 A:DO1601 2.7 24.9 1.0 C07 A:DO1601 3.1 24.2 1.0 O A:HOH836 3.3 45.8 1.0 C06 A:DO1601 3.5 20.0 1.0 C26 A:DO1601 3.7 17.3 1.0 O A:HOH850 3.9 46.5 1.0 ND1 A:HIS483 4.0 19.9 1.0 C11 A:DO1601 4.0 26.2 1.0 C09 A:DO1601 4.0 25.4 1.0 O A:HOH767 4.2 45.9 1.0 CE1 A:HIS483 4.2 20.0 1.0 CB A:PHE480 4.3 15.7 1.0 O15 A:DO1601 4.3 29.1 1.0 CG A:HIS483 4.4 20.5 1.0 N A:CYS481 4.4 18.0 1.0 SG A:CYS481 4.4 29.6 1.0 O A:CYS481 4.5 17.0 1.0 C10 A:DO1601 4.5 25.3 1.0 N05 A:DO1601 4.5 16.8 1.0 C16 A:DO1601 4.5 33.0 1.0 NE2 A:HIS483 4.8 21.4 1.0 CA A:PHE480 4.8 15.9 1.0 C27 A:DO1601 4.8 16.0 1.0 O A:GLN535 4.9 29.5 1.0 O A:HOH808 4.9 44.0 1.0 CD2 A:HIS483 4.9 21.2 1.0 CB A:HIS483 4.9 19.2 1.0 C A:PHE480 4.9 16.9 1.0

J.R.Horton, X.Liu, L.Wu, K.Zhang, J.Shanks, X.Zhang, G.Rai, B.T.Mott, D.J.Jansen, S.C.Kales, M.J.Henderson, K.Pohida, Y.Fang, X.Hu, A.Jadhav, D.J.Maloney, M.D.Hall, A.Simeonov, H.Fu, P.M.Vertino, Q.Yan, X.Cheng. Insights Into the Action of Inhibitor Enantiomers Against Histone Lysine Demethylase 5A. J. Med. Chem. V. 61 3193 2018.
ISSN: ISSN 1520-4804
PubMed: 29537847
DOI: 10.1021/ACS.JMEDCHEM.8B00261